CIK 0001625297 · Large accelerated filer
Supernus, Inc.
Sign in to watch- Tickers
- INDV SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 412520873
- Phone
- 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
Securities
- INDV Common stock Nasdaq
- SUPN Common Stock Nasdaq
- 4 Planned sale Chief Scientific Officer sold 18,586 shares at $41.14 ($764,628)
- 4 Shares withheld for taxes Chief Executive Officer gave up 612,549 shares (to pay taxes)
- 4 Planned sale Chief Scientific Officer sold 18,586 shares at $38.06 ($707,383)
- 4 Planned sale Chief Financial Officer sold 36,000 shares at $37.70 ($1,357,200)
- 4 Shares withheld for taxes Director gave up 1,117 shares (to pay taxes)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 6,518 shares (grant or award)
- 4 Grant or award Director acquired 10,430 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,843 shares (to pay taxes)
- 4 Open-market buy Director bought 8 shares at $31.09 ($249)
- 4 Open-market buy Director bought 940 shares at $31.87 ($29,953)
- 4 Open-market buy Director bought 31 shares at $32.56 ($1,009)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 10,965 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 87,597 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 36,032 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 45,797 shares (to pay taxes)
- 4 Grant or award Chief Accounting Officer acquired 6,903 shares (grant or award)
Page 2 of 4 · 70 filings